Obstetrics and Contraceptive Issues

Jeffrey T. Jensen; Bruce R. Carr Guest Editors

doi:10.1055/s-0032-1328872

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2012; 30(06): 457-458
DOI: 10.1055/s-0032-1328872

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Obstetrics and Contraceptive Issues

Jeffrey T. Jensen

¹Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, Oregon

,

Bruce R. Carr Guest Editors

²Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

References
1 Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012; 307 (5) 491-497
2 Kaneshiro B. Contraceptive use and sexual behavior in obese women. Semin Reprod Med 2012; 30 (6) 457-462
3 Edelman AB, Jensen JT. Obesity and hormonal contraception: safety and efficacy. Semin Reprod Med 2012; 30 (6) 477-483
4 Marshall NE, Spong CY. Obesity, pregnancy complications, and birth outcomes. Semin Reprod Med 2012; 30 (6) 463-469
5 Frias AE, Grove KL. Obesity: A Transgenerational problem linked to nutrition during pregnancy. Semin Reprod Med 2012; 30 (6) 470-476
6 Cole JA, Norman H, Doherty M, Walker AM. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 2007; 109 (2 Pt 1) 339-346
7 van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ 2009; 339: b2921
8 Centers for Disease Control and Prevention. U.S. medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep 2010; 59 (RR-4) 1-86